Mantle Cell Lymphoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies
Not yet recruiting
  • Follicular Lymphoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-12-02
Dec 2, 2021
J
A Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Given in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma
Active, not recruiting
  • Mantle Cell Lymphoma
  • Tucson, Arizona
  • +202 more
2021-12-02
Dec 2, 2021
E
Study of XL114 in Subjects With Non-Hodgkin's Lymphoma
Not yet recruiting
  • Non-Hodgkin's Lymphoma
  • +4 more
  • (no location specified)
2021-11-22
Nov 22, 2021
C
CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies
Recruiting
  • Relapsed/Refractory B-cell Lymphomas
  • +8 more
  • CLBR001 and SWI019
  • Duarte, California
  • +7 more
2021-11-30
Nov 30, 2021
A
A Disease Registry of Patients With Mantle Cell Lymphoma
Recruiting
  • Mantle Cell Lymphoma
    • Decatur, Alabama
    • +53 more
    2021-11-22
    Nov 22, 2021
    U
    Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
    Recruiting
    • Mantle Cell Lymphoma
    • +5 more
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    2021-11-19
    Nov 19, 2021
    C
    Study of CLR 131 in Select B-Cell Malignancies (CLOVER-1) and Pivotal Expansion in Waldenstrom Macroglobulinemia
    Recruiting
    • Waldenstrom Macroglobulinemia
    • +8 more
    • CLR 131 single dose
    • +2 more
    • Redlands, California
    • +14 more
    2021-11-30
    Nov 30, 2021
    M
    Sequential Chemo-Radioimmunotherapy Followed by Autologous Transplantation for Patients With Untreated Advanced Stage Mantle Cell Lymphoma
    Active, not recruiting
    • Mantle Cell Lymphoma
    • R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.
    • Basking Ridge, New Jersey
    • +4 more
    2021-12-01
    Dec 1, 2021
    B
    Brief Title: Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab
    Recruiting
    • Chronic Lymphocytic Leukemia
    • +8 more
    • Adelaide, Australia
    • +6 more
    2021-11-29
    Nov 29, 2021
    I
    A Study of Parsaclisib, a PI3Kδ Inhibitor, in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma
    Not yet recruiting
    • Mantle Cell Lymphoma
    • (no location specified)
    2021-11-22
    Nov 22, 2021
    S
    Orelabrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma
    Recruiting
    • High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements
    • +4 more
    • Orelabrutinib+R-CHOP; Orelabrutinib+R-DA-EPOCH; Orelabrutinib+R-HD MTX;Orelabrutinib+R+other chemotherapies
    • Jinan, Shandong, China
      Shandong Provincial Hospital
    2021-11-18
    Nov 18, 2021
    S
    Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived Malignancies
    Active, not recruiting
    • B Cells-Tumors
    • +4 more
    • Idelalisib 100 MG
    • Placebo Oral Tablet
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    2021-11-17
    Nov 17, 2021
    N
    NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
    Recruiting
    • Lymphoma, Non-Hodgkin
    • +9 more
    • NKX019
    • Denver, Colorado
    • +4 more
    2021-11-16
    Nov 16, 2021
    E
    Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma
    Recruiting
    • Chronic Lymphocytic Leukemia
    • +4 more
    • Inactivated Influenza Vaccine
    • Atlanta, Georgia
    • +1 more
    2021-11-08
    Nov 8, 2021
    F
    Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.
    Not yet recruiting
    • Mantle Cell Lymphoma
      • Milano, MI, Italy
      • +29 more
      2021-11-11
      Nov 11, 2021
      T
      Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
      Active, not recruiting
      • Diffuse Large B-Cell Lymphoma
      • +4 more
      • Ublituximab
      • +2 more
      • Birmingham, Alabama
      • +167 more
      2021-11-11
      Nov 11, 2021
      M
      Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant
      Recruiting
      • Acute Lymphoblastic Leukemia
      • +12 more
      • Anti-Thymocyte Globulin
      • +5 more
      • Houston, Texas
        M D Anderson Cancer Center
      2021-11-09
      Nov 9, 2021
      T
      A Study of OLR in First-line Treatment of Mantle Cell Lymphoma
      Recruiting
      • Mantle Cell Lymphoma
      • Orelabrutinib in in combination of rituximab and lenalidomide(OLR)
      • Tianjin, Tianjin, China
        Tianjin Medical University Cancer Insititute & Hospital
      2021-11-03
      Nov 3, 2021
      J
      A Long-term Extension Study of PCI-32765 (Ibrutinib)
      Enrolling by invitation
      • Chronic Lymphocytic Leukemia
      • +6 more
      • Duarte, California
      • +166 more
      2021-11-04
      Nov 4, 2021
      G
      Ibrutinib in Combination With Rituximab in Patients With Indolent Clinical Forms of MCL
      Active, not recruiting
      • Mantle Cell Lymphoma
      • Terrassa, Barcelona, Spain
      • +14 more
      2021-11-03
      Nov 3, 2021
      N
      Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma
      Recruiting
      • B-cell Lymphoma
      • +8 more
      • Polatuzumab vedotin
      • Valhalla, New York
        New York Medical Center
      2021-10-29
      Oct 29, 2021
      V
      A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001)
      Recruiting
      • Chronic Lymphocytic Leukemia
      • +11 more
      • Zilovertamab vedotin
      • Duarte, California
      • +11 more
      2021-11-02
      Nov 2, 2021
      N
      Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
      Recruiting
      • CLL/SLL
      • +6 more
      • Cincinnati, Ohio
      • +2 more
      2021-11-02
      Nov 2, 2021
      W
      Acalabrutinib-Lenalidomide-Rituximab in Patients With Untreated MCL
      Recruiting
      • Mantle Cell Lymphoma
      • New York, New York
        Weill Cornell Medicine
      2021-10-29
      Oct 29, 2021
      S
      Phase II Trial of Venetoclax and Rituximab as Initial Therapy in Older Patients With Mantle Cell Lymphoma
      Recruiting
      • Mantle Cell Lymphoma
      • Venetoclax Oral Tablet [Venclexta]
      • Baltimore, Maryland
        Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      2021-10-20
      Oct 20, 2021